Natural history of DM: Focus on micro- and macrovascular complications
5 Things a cardiologist needs to know about diabetes
Prof. Ray focuses on micro- and macrovascular disease in type 2 diabetes, their implications, their interrelationship and how these risks can be modified by new glucose-lowering agents.
Video navigation menu
- Prevalence, risk factors, progression and impact of diabetes 00:38
- Diabetes is a progressive disease 01:27
- Macrovascular and microvascular complications and their relationship 03:18
- New glucose-lowering agents improve CV outcomes 05:50
- Novel class of diabetes drugs may reduce microvascular complications 09:39
This educational video is part of a series called '5 Things a cardiologist needs to know about diabetes' that are aimed to guide cardiologists in management of patients with type 2 diabetes, since the cardiology practice is increasingly confronted with these patients. This series covers five topics that help cardiologists understand what is important when treating patients with diabetes, and what risks these patients face.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.
Kausik Ray, MD, is a cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom.
This educational series is funded by an unrestricted educational grant provided by Merck & Pfizer.
This is available as accredited online CME for members. Click the button below to enroll:Enroll
Share this page with your colleagues and friends: